ALX Oncology
ALXO
ALXO
110 hedge funds and large institutions have $293M invested in ALX Oncology in 2024 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 37 increasing their positions, 26 reducing their positions, and 24 closing their positions.
Holders
110
Holders Change
+4
Holders Change %
+3.77%
% of All Funds
1.6%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
30
Increased
37
Reduced
26
Closed
24
Calls
$3.33M
Puts
$1.9M
Net Calls
+$1.43M
Net Calls Change
+$250K
Top Buyers
| 1 |
PBA
1
Paradigm Biocapital Advisors
New York
|
$9.5M |
| 2 |
2
Millennium Management
New York
|
$7.99M |
| 3 |
VPC
3
Vestal Point Capital
New York
|
$21.7M |
| 4 |
MB
4
MPM BioImpact
Boston,
Massachusetts
|
$13.2M |
| 5 |
5
Marshall Wace
London,
United Kingdom
|
$3.83M |
